We are live on ! Find out more
IMA

ImageneBio Inc
IMA

34 hedge funds and large institutions have $69.8M invested in ImageneBio Inc in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

0% more ownership

Funds ownership: 6.03% → 6.04% (+0%)

16% less capital invested

Capital invested by funds: $82.8M → $69.8M (-$13M)

19% less funds holding

Funds holding: 42 → 34 (-8)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
34
Holders Change
-8
Holders Change %
-19.05%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
10
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.19M
2
CA
CHI Advisors
New York
+$1.13M
3
Verition Fund Management
Verition Fund Management
Connecticut
+$749K
4
State Street
State Street
Massachusetts
+$51.1K
5
Millennium Management
Millennium Management
New York
+$27.2K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.77M
2
HM
HealthCor Management
New York
-$781K
3
BlackRock
BlackRock
New York
-$524K
4
E
Ergoteles
New York
-$221K
5
Morgan Stanley
Morgan Stanley
New York
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$13.3M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$9.91M +$3.19M +99,864 +47%
O
3
OrbiMed
New York
$7.8M – – –
BI
4
BVF Inc
California
$6.66M – – –
OFM
5
Omega Fund Management
Massachusetts
$5.98M – – –
Citadel Advisors
6
Citadel Advisors
Florida
$5.73M -$8.88K -278 -0.2%
CA
7
CHI Advisors
New York
$4.36M +$1.13M +35,256 +35%
Verition Fund Management
8
Verition Fund Management
Connecticut
$4.2M +$749K +23,427 +22%
AG
9
Artal Group
Luxembourg
$4.12M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.61M +$1.34K +42 +0.1%
LCM
11
Laurion Capital Management
New York
$1.41M – – –
BlackRock
12
BlackRock
New York
$812K -$524K -16,395 -39%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$628K -$1.37K -43 -0.2%
Barclays
14
Barclays
United Kingdom
$530K -$4.86K -152 -0.9%
OMC
15
Oasis Management Company
Cayman Islands
$372K – – –
DCM
16
DAFNA Capital Management
California
$326K – – –
Ensign Peak Advisors
17
Ensign Peak Advisors
Utah
$240K – – –
BCM
18
Bridgeway Capital Management
Texas
$238K -$5.72K -179 -2%
State Street
19
State Street
Massachusetts
$135K +$51.1K +1,600 +61%
CIC
20
Cornercap Investment Counsel
Georgia
$78.4K – – –
Northern Trust
21
Northern Trust
Illinois
$72.1K -$320 -10 -0.4%
E
22
Ergoteles
New York
$46.8K -$221K -6,920 -83%
TRCT
23
Tower Research Capital (TRC)
New York
$37K +$26.8K +840 +263%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$34K – – –
Charles Schwab
25
Charles Schwab
California
$32.1K – – –
1
2

IMA Hedge Fund Activity: Q4 2022 in Review

34 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2022, worth a combined $69.8M — down 16% from $82.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMA and 2 opened new positions — a net loss of 8 holders — while 9 trimmed existing stakes and 10 added.

The largest buyer was Fidelity Investments, adding an estimated $3.19M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $4.77M sold.

  • 34 institutional investors held ImageneBio Inc (IMA) as of Q4 2022, down from 42 in Q3 2022.
  • Funds reported $69.8M of ImageneBio Inc stock for Q4 2022, down 16% quarter-over-quarter.
  • 2 funds opened new ImageneBio Inc positions in Q4 2022 and 10 closed out, a net change of -8 holders.
  • The largest ImageneBio Inc buyer in Q4 2022 was Fidelity Investments, an estimated $3.19M added.
  • The largest ImageneBio Inc seller in Q4 2022 was Point72 Asset Management, an estimated $4.77M sold.

Based on aggregated 13F filings for Q4 2022.